This is the authors' abstract. We don't add key points for this paper.
Infectious disease modelling can serve as a powerful tool for situational awareness and decision support for policy makers. However, COVID-19 modelling efforts faced many challenges, from poor data quality to changing policy and human behaviour. To extract practical insight from the large body of COVID-19 modelling literature available, we provide a narrative review with a systematic approach that quantitatively assessed prospective, data-driven modelling studies of COVID-19 in the USA. We analysed 136 papers, and focused on the aspects of models that are essential for decision makers. We have documented the forecasting window, methodology, prediction target, datasets used, and geographical resolution for each study. We also found that a large fraction of papers did not evaluate performance (25%), express uncertainty (50%), or state limitations (36%). To remedy some of these identified gaps, we recommend the adoption of the EPIFORGE 2020 model reporting guidelines and creating an information-sharing system that is suitable for fast-paced infectious disease outbreak science.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Nixon et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: